| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/2004 | WO2004016762A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016745A2 Backterial effector proteins which inhibit programmed cell death |
| 02/26/2004 | WO2004016744A2 Treatment of liver deseases |
| 02/26/2004 | WO2004016739A2 Cell modulation using a cytoskeletal protein |
| 02/26/2004 | WO2004016738A2 Method and composition for treating and preventing hepatitis c infection |
| 02/26/2004 | WO2004016737A2 Novel htnfsf13b protein variants |
| 02/26/2004 | WO2004016736A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016734A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016733A2 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016732A2 Astrocyte modulated genes and uses thereof |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016654A1 Il-8 like protein |
| 02/26/2004 | WO2004016653A2 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 02/26/2004 | WO2004016652A2 Mammaglobin promoter |
| 02/26/2004 | WO2004016651A2 Spider silk polypeptide |
| 02/26/2004 | WO2004016650A1 Antimicrobial peptides, polypeptides comprising same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 02/26/2004 | WO2004016649A2 Method for the production of an artificial polypeptide and artificial proteins produced by said method |
| 02/26/2004 | WO2004016648A1 Fluorescent protein |
| 02/26/2004 | WO2004016647A2 Fragments of proinsulin c-peptide |
| 02/26/2004 | WO2004016643A2 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 02/26/2004 | WO2004016641A2 Proteins involved in the regulation of energy homeostasis |
| 02/26/2004 | WO2004016639A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | WO2004016637A1 Gene families associated with liver cancer |
| 02/26/2004 | WO2004016636A1 Gene families associated with stomach cancer |
| 02/26/2004 | WO2004016317A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/26/2004 | WO2004016283A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | WO2004016282A1 Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 02/26/2004 | WO2004016280A1 Recombinant bcg vaccine |
| 02/26/2004 | WO2004016274A2 Novel peptide-conjugated oligomeric compounds |
| 02/26/2004 | WO2004016230A2 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 02/26/2004 | WO2004016229A2 Compositions and methods for treating rage-associated disorders |
| 02/26/2004 | WO2004016228A2 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS |
| 02/26/2004 | WO2004016222A2 Hepatitis c viral-like particle purification |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004016148A2 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
| 02/26/2004 | WO2004016082A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | WO2004007532A9 Beta-sheet forming peptides and material made thereof |
| 02/26/2004 | WO2004005341A3 Full-length interferon gamma polypeptide variants |
| 02/26/2004 | WO2004005336A3 β-SHEET BREAKING PEPTIDES |
| 02/26/2004 | WO2004005335A3 Multimerised growth hormone fusion proteins |
| 02/26/2004 | WO2004004763A3 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 02/26/2004 | WO2004003010A3 Nuclear hormone receptor ligano-binding domain containing protein |
| 02/26/2004 | WO2004003009A3 Francisella tularensis immunogenic proteins and dna encoding these |
| 02/26/2004 | WO2004000881A9 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 02/26/2004 | WO2003105758A3 Cancer-linked gene as target for chemotherapy |
| 02/26/2004 | WO2003104437A3 Anti-addl antibodies and uses thereof |
| 02/26/2004 | WO2003098991A3 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2004 | WO2003097813A3 Regulation of staphylococcus aureus biofilm formation |
| 02/26/2004 | WO2003097688A3 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/26/2004 | WO2003094862A3 tRNA SYNTHASE: MODULATORS OF ANGIOGENESIS |
| 02/26/2004 | WO2003093415A3 Methods useful in treatment and prevention of hiv infection |
| 02/26/2004 | WO2003089602A3 Toll-like receptor 11 and toll-like receptor 12 |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003087132A3 Compositions and methods for evaluating and designing nuclear receptor ligands that modulate co-regulator affinity |
| 02/26/2004 | WO2003086491A3 Tissue defect dressings comprising a keratin network |
| 02/26/2004 | WO2003086301A3 Antibodies that specifically bind to tr2 |
| 02/26/2004 | WO2003086296A3 Treatment for type 1 diabetes before and after expression of predisposition markers. |
| 02/26/2004 | WO2003083117A3 Vascularization controlling gene |
| 02/26/2004 | WO2003083050A3 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/26/2004 | WO2003078651A3 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 02/26/2004 | WO2003068911A3 Citrus tristeza virus resistance genes and methods of use |
| 02/26/2004 | WO2003068805A3 Formulation strategies in stabilizing peptides in organic solvents and in dried states |
| 02/26/2004 | WO2003063769A3 Vesicle-associated proteins |
| 02/26/2004 | WO2003062401A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 02/26/2004 | WO2003061583A3 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003059934A3 Albumin fusion proteins |
| 02/26/2004 | WO2003057892A3 Viruses with enhanced lytic potency |
| 02/26/2004 | WO2003056299A3 Labeling reagent and methods of use |
| 02/26/2004 | WO2003054147A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | WO2003054140A9 Phosphate limited inducible promoter and a bacillus expression system |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003049684A3 Pseudo-antibody constructs |
| 02/26/2004 | WO2003048194A3 Peptide or protein containing a c'-d loop of the cd28 receptor family |
| 02/26/2004 | WO2003046139A3 CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE |
| 02/26/2004 | WO2003044175A3 Methods and use of motoneuronotropic factors |
| 02/26/2004 | WO2003042232A3 Crystals and structures of yiim proteins |
| 02/26/2004 | WO2003040325A3 Novel proteins and nucleic acids encoding same |
| 02/26/2004 | WO2003039245A3 Transgenic mice knockout for histamine receptor h3 gene |
| 02/26/2004 | WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003035837A3 Novel compositions and methods for cancer |
| 02/26/2004 | WO2003033530A3 Mycobacterial antigens expressed under high oxygen tension |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003020899A3 Compositions and methods relating to lung specific genes and proteins |
| 02/26/2004 | WO2003020892A3 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 02/26/2004 | WO2003018516A3 Glucagon-like peptide-1 analogs |
| 02/26/2004 | WO2003016472A9 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/26/2004 | WO2003015708A3 Composition and method for treating hiv infection |
| 02/26/2004 | WO2003012148A3 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2003011892A3 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/26/2004 | WO2003010320A3 Recombinant vector derived from adeno-associated virus for gene therapy |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2003006641A9 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 02/26/2004 | WO2003006485A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/26/2004 | WO2003004611A3 Human olfactory nucleotide-gated ion channels |
| 02/26/2004 | WO2002090506A3 Metabolite transporters |
| 02/26/2004 | WO2002088378A3 66784, a novel human potassium channel and uses therefor |